Screening at 24-28 weeks GA under the new IADPSG guidelines with the 2h GTT is expensive but cost-effective in improving maternal and neonatal outcomes (American Journal of Obstetrics & Gynecology)
Diabetes News Service
Screening at 24-28 weeks GA under the new IADPSG guidelines with the 2h GTT is expensive but cost-effective in improving maternal and neonatal outcomes (American Journal of Obstetrics & Gynecology)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales